Latest Breaking News On - Uwe platzbecker - Page 2 : comparemela.com

Imetelstat leads to durable red blood cell transfusion independence

Imetelstat leads to durable red blood cell transfusion independence
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Mrinalm patnaikUwe platzbeckerJanssen research developmentUniversity hospital leipzigGeron corporation

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Uwe platzbeckerEuropean medicines agencyUniversity of leipzig medical centerDepartment for hematologyDrug administrationLeipzig universityGeron corporationProfessor uwe platzbeckerLeipzig medical centerCell therapyInfectious diseasesLeipzig medicalProfessor platzbecker

Phase III data for novel telomerase inhibitor imetelstat released

Phase III data for novel telomerase inhibitor imetelstat released
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Uwe platzbeckerFaye fellerDrug administrationEuropean medicines agencyLeipzig university hospitalDepartment of hematologyCellular therapyInfectious diseasesExecutive vice presidentChief medical officer

Geron Announces Publication in The Lancet of Results from the IMerge Phase 3 Clinical Trial Evaluating Imetelstat in Lower Risk MDS

Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS .

United statesFaye fellerUwe platzbeckerExchange commissionEuropean medicines agencyDrug administrationDepartment of hematologyGeron corporation nasdaqLeipzig university hospitalEuropean unionGeron corporationExecutive vice presidentChief medicalCellular therapyInfectious diseasesNorth america

Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS

40% of patients treated with imetelstat were transfusion-free for at least 8 weeks

United statesMayo clinic in rochesterMrinal patnaikUwe platzbeckerMike bassettUniversity hospital leipzigMayo clinic